Primary study · included by 1 review
Multimodal profiling uncovers tertiary lymphoid structures as a critical determinant of immunotherapy response and prognosis in nasopharyngeal carcinoma.
Li H 2025 · Li Hui, Lou Liming, Du Juan, et al. · Oral oncology · 2025
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Overall survival Absence of tertiary lymphoid structures (TLS-negative tumors) vs Presence of tertiary lymphoid structures (TLS-positive tumors, reference category) · Follow-up 24 to 120 months | HR 2.20 [1.74, 2.78] | 7 studies · 1465 participants | GRADE not reported |
1 including review in total.